Minimal residual disease in acute lymphoblastic leukemia - Wikidata - wikimedia - TriplyDB

Minimal residual disease in acute lymphoblastic leukemia

Minimal residual disease in acute lymphoblastic leukemia

http://www.wikidata.org/entity/Q37077352

about

Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia A new method for high speed, sensitive detection of minimal residual disease.High-risk childhood acute lymphoblastic leukemia The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia.BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia.Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia Improved prognosis for older adolescents with acute lymphoblastic leukemia.Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia Quantitative detection of the human cervical cancer oncogene for monitoring the minimal residual disease in acute leukemia Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia.Therapy of Philadelphia chromosome-negative acute lymphoblastic leukemia in adults: new paradigms.Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.Adult acute lymphoblastic leukemia: concepts and strategies.Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians.Flow cytometry in hematological disorders.Leukemias in Children.Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group.Acute lymphoblastic leukemia: a comprehensive review and 2017 update Enhanced sensitivity of flow cytometry for routine assessment of minimal residual disease.Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.Towards automation of flow cytometric analysis for quality-assured follow-up assessment to guide curative therapy for acute lymphoblastic leukaemia in children Characterizing Deformability of Drug Resistant Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells Using Acoustic Tweezers

P2860

Q28394142-75D199F9-6775-4CCD-8C4A-231AD856DCC8 Q28943431-94F58004-5ECB-48E9-A075-A8B3871ABD45 Q31030896-32558530-A6D2-431A-AAB7-1B3C01E1517E Q33622837-FC6BBE56-ACE3-4D17-A17B-90DD6F72DE43 Q33919296-554CE5E8-5749-44D7-BDB1-20AF83EEDD4A Q34358853-27E74462-4D74-4E38-B533-A47C76974E32 Q34449151-08C0AEE3-155D-4137-92D3-B046D19C90D5 Q34679298-B012D1B8-FF6E-4682-B37D-47D3FF3E622B Q36371093-8159FF92-8636-45B2-B54F-C289A64F8C2F Q37070953-C3F3A67A-F7BD-468B-BA41-01D43FC9D7D6 Q37389544-2F5CE257-A821-4A74-8BCD-D89E233926A8 Q37605864-CE6DBFF7-3B9A-4B71-AA48-CC2BF99FF782 Q37613872-3CEC5003-C497-4643-BDAC-9F738B9B0658 Q37681450-5BBCDABB-A5F4-4437-BCAF-EDC48A1DA28C Q37847072-BBF9D165-D94A-4A9C-A09C-A53D708C7134 Q38128814-2CF2F22C-C577-4053-9D96-1D3A8A12CEA2 Q38355065-73A2D17E-998B-42FD-BE01-F48D5372A6F1 Q38749564-77249B4D-3A51-4EDC-ADF2-A4DDEF961B41 Q39406969-97EEC9E4-6305-415E-811E-634DBC699181 Q42832364-416CCE54-55C8-44F6-97E1-2DDC76DFFFD2 Q43221788-646EB45E-FF44-4E3A-986F-696BF6C75937 Q51746464-BD747F6B-7AA2-4733-8AA3-C54ADC9CB2BF Q57566668-6AA7D9FD-C78F-4CE3-8B2A-D4D08FEA91CE Q57794620-9503336B-78C9-4843-AAB5-09124F84E40E

P2860

Minimal residual disease in acute lymphoblastic leukemia

http://www.wikidata.org/entity/Q37077352

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Minimal residual disease in acute lymphoblastic leukemia

@en

Minimal residual disease in acute lymphoblastic leukemia.

@nl

type

label

Minimal residual disease in acute lymphoblastic leukemia

@en

Minimal residual disease in acute lymphoblastic leukemia.

@nl

prefLabel

Minimal residual disease in acute lymphoblastic leukemia

@en

Minimal residual disease in acute lymphoblastic leukemia.

@nl

P1433

Q37077352-B64B0D55-DF02-4A55-BA0D-50CA3FBB2819

P1476

Q37077352-15C5106B-2B62-4515-B947-F138F24AD286

P2093

Q37077352-9D15BF6A-E0AE-475B-A497-72AE2EC275AE

P2860

Q37077352-04B4B17A-751F-4408-9420-908AF3E15102

Q37077352-1288E14E-7F50-4A84-B7E8-4BCE5C65640C

Q37077352-16958105-14C6-4CDA-A7E3-43222E3D8611

Q37077352-18CB877A-1056-406D-8113-B708846CFF00

Q37077352-1AB1D9C2-F60E-414A-BEC3-19B4591E12FF

Q37077352-1C8006F5-96BB-456E-AA57-B6C31C249D7F

Q37077352-2637169E-3C5B-46C5-B4B1-60CDCAD1490D

Q37077352-2BF49845-5DB5-42D8-B5CD-2816C0498ABD

Q37077352-2E567AFF-BFF4-4B4A-9C0E-E96B709B32C1

Q37077352-3E2DF0DD-9333-4269-84F9-11550597C1D7

P304

Q37077352-AE589303-C9E4-485C-84C9-9CA3A5884B64

P31

Q37077352-60270570-269E-4201-85D5-7AA35F1C8E4B

P356

Q37077352-32A9765F-6C29-4A81-8CDF-2E678684ECD7

P433

Q37077352-8D0021F4-61E1-4687-81F4-C89F39EACA94

P478

Q37077352-6736DEAE-D8F4-449C-94E2-A00629558D14

P577

Q37077352-AF389A65-8356-4BA0-960E-FB2A0FECB23D

P698

Q37077352-F07B1BDB-0D0E-42CE-83B9-47D14BA06E1B

P921

Q37077352-E70FDC90-7456-464D-80FE-8C62054FE22D

P932

Q37077352-5DBF2ED9-5FBA-460B-8A88-2B6E2C84EDE4

P356

J.SEMINHEMATOL.2008.09.001

P1433

Seminars in Hematology

P1476

Minimal residual disease in acute lymphoblastic leukemia

@en

P2093

Dario Campana

http://www.w3.org/2001/XMLSchema#string

P2860

Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2

Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials.

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

Detection of minimal residual disease in acute leukemia by flow cytometry.

Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation.

Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction.

Minimal residual disease in leukaemia patients.

P304

100-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.SEMINHEMATOL.2008.09.001

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19100372

http://www.w3.org/2001/XMLSchema#string

P921

P932

2632881

http://www.w3.org/2001/XMLSchema#string